Create a narrative

BeOne Medicines Community

NasdaqGS:ONC Community

1 Narratives written by author
0 Comments on narratives written by author
17 Fair Values set on narratives written by author

BeOne Medicines

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 24 Analysts

Oncology Trials And Global Expansion Will Unlock Future Markets

Key Takeaways Rapid commercial expansion and innovative therapies drive sustained growth, with a strong product pipeline supporting future revenue and margin improvement. Operational efficiencies and new product formulations position the company for enhanced profitability and resilience against external cost pressures.

US$357.27

FV

10.1% undervalued

18.44%

Revenue growth p.a.

0

0

7

3 days ago